Cradel Pharmaceuticals Pvt Ltd

Cradel Pharmaceuticals Pvt Ltd - chemicals and materials in Pailan Hut, West Bengal, India. FY 2026 financials & compliance.
CIN U24233WB1991PTC050938 Incorporated 21 February 1991 ROC Kolkata HQ Pailan Hut, West Bengal, India
Active Private Limited Company chemicals and materials MSME · Small
Revenue · FY 2025
₹7.07 Lakh
▲ 15% YoY
Net loss · FY 2025
₹65,561
Net margin -9.3%
EBITDA · FY 2025
₹82,430
EBITDA margin 11.7%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹40,000
Issued & subscribed
Open charges
₹9.07 Cr
Satisfied ₹32.44 Cr
Company age
35 yrs
Est. 1991
Employees · EPFO
87
Provident fund records

About Cradel Pharmaceuticals Pvt Ltd

Data last updated:

Cradel Pharmaceuticals Pvt Ltd is a private limited company based in Pailan Hut, West Bengal, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 21 February 1991 and has been in existence for over 35 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24233WB1991PTC050938. Its GSTIN is 19AABCC0202E1ZG (West Bengal).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹40,000. It is led by directors including Roochira Guha and Manab Kumar Bakshi.

Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 247 Diamond Harbour Road P.O – Pailan Hut Raspunja South 24 Parganas, West Bengal, India – 700104.

As per the financials filed for FY 2025, the company reported a revenue of ₹7.07 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net loss of ₹65,561 (net margin -9.3%) and EBITDA of ₹82,430 (EBITDA margin 11.7%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 60% over five years.

The company has about 87 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Cradel Pharma. As per MCA filings, the company has open charges of ₹9.07 Cr and satisfied charges of ₹32.44 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 1 case is pending.

Cradel Pharmaceuticals Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-18-0003991). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cradelpharma.com.

Company details

CIN U24233WB1991PTC050938
Registration Number 050938
Incorporation Date 21 February 1991
ROC Kolkata
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-18-0003991

Recognitions & Rankings of Cradel Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-WB-18-0003991

Contact details

Cradel Pharmaceuticals Pvt Ltd's registered office is in Pailan Hut, West Bengal. Its website is cradelpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    247 Diamond Harbour Road P.O – Pailan Hut Raspunja South 24 Parganas, West Bengal, India – 700104
  • Industry
    Chemicals and Materials, Specialty Chemicals

To see the full contact details of Cradel Pharmaceuticals Pvt Ltd, buy the company report.

Comprehensive company report
Cradel Pharmaceuticals Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Cradel Pharmaceuticals operates one associated brand: Cradel Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Produces high-quality oral liquid pharmaceuticals for the healthcare industry.cradelpharma.com

Business activity

The main business activity of Cradel Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Cradel Pharmaceuticals Pvt Ltd, buy the company report.

Financials of Cradel Pharmaceuticals Pvt Ltd

FY 2025 filings available

Cradel Pharmaceuticals Pvt Ltd reported revenue of ₹7.07 Lakh (up 15% YoY) for FY 2025.

Revenue · FY 2025
₹7.07 Lakh ▲ 15%
Net loss · FY 2025
₹65,561 margin -9.3%
EBITDA · FY 2025
₹82,430 margin 11.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 6%
5 years · compounded
▼ 60%
EBITDA CAGR growth
1 year
▲ 492%
3 years · compounded
▼ 3%
5 years · compounded
▼ 65%

Revenue rose 15% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 60%. EBITDA rose 492% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹82,430
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹65,561
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.7%
Net Profit Margin-9.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cradel Pharmaceuticals Pvt Ltd, buy the company report.

Board of directors of Cradel Pharmaceuticals Pvt Ltd

Cradel Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Roochira GuhaDirector16 Jan 20197 Years 9 MonthsCurrent
Manab Kumar BakshiDirector21 Feb 199135 Years 8 MonthsCurrent
Neelanjana BindraDirector22 Mar 201313 Years 7 MonthsCurrent

Peer comparison

Cradel Pharmaceuticals Pvt Ltd is compared with the 5 companies closest to it by revenue in the Chemicals industry (Formulations, Pharmaceuticals, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Svizera Healthcare Private Limited₹7.1 Lakh (FY 2023)Mumbai, Maharashtra, India
Gundicha Pharmaceuticals Private Limited₹7.09 Lakh (FY 2020)-7.0%Mumbai, Maharashtra, India
Lionise Pharmaceuticals Private Limited₹7.09 Lakh (FY 2021)450.0%New Delhi, Delhi, India
Welsave Pharmaceuticals Private Limited₹7.07 Lakh (FY 2025)70.0%Delhi, India
Cradel Pharmaceuticals Pvt Ltdthis company₹7.07 Lakh (FY 2025)-₹65,561-9.3%15.0%87Pailan Hut, West Bengal, India
Aru Healthcare Private Limited₹7.06 Lakh (FY 2025)-96.0%Begrajpur, Muzaffarnagar, Uttar Pradesh, India

To see the full peer comparison of Cradel Pharmaceuticals Pvt Ltd, buy the company report.

Auditor

Cradel Pharmaceuticals Pvt Ltd is audited by GHOSAL BARNWAL & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
GHOSAL BARNWAL & CO.FY 2023324914E

Shareholding

The shareholding of Cradel Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Cradel Pharmaceuticals Pvt Ltd, buy the company report.

Charges & borrowings

Open charges
₹9.07 Cr
Satisfied charges
₹32.44 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹9.07 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Aug 2023100817323Hdfc Bank Limited₹17 LakhOpen
02 Sep 2022100617525Hdfc Bank Limited₹8.9 CrOpen
28 Jun 2021100455870Tata Capital Financial Services Limited₹6.5 CrSatisfied
20 Jun 2018100185461Others₹5.92 CrSatisfied
18 Sep 201410524894Axis Bank Limited₹4.15 CrSatisfied

To see the full charge records of Cradel Pharmaceuticals Pvt Ltd, buy the company report.

Total charge records: 9 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Cradel Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Cradel Pharmaceuticals Pvt Ltd has a workforce of 87 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.

Employee count
87
Active EPFO establishments
1
Employee growth
-14.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2787
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Cradel Pharmaceuticals Pvt Ltd, buy the company report.

GST

Cradel Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AABCC0202E1ZGWest BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Cradel Pharmaceuticals Pvt Ltd, buy the company report.

Recent activity

Cradel Pharmaceuticals Pvt Ltd has 5 board changes on record since 1991: 4 appointments and 1 cessation. The latest: Krishna Bakshi ceased to be Director on 29 Jan 2022.

AGM
Cradel Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Cradel Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 17.00 Lakh with Charge ID 100817323 was registered on 29 Aug 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 890.00 Lakh registered on 02 Sep 2022 with Charge ID 100617525 was modified on 09 Feb 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 890.00 Lakh with Charge ID 100617525 was registered on 02 Sep 2022.
Charges
A charge registered on 28 Jun 2021 via Charge ID 100455870 with Tata Capital Financial Services Limited was fully satisfied on 26 Aug 2022.
Ceased
Krishna Bakshi ceased to be Director.
Charges
A charge with Tata Capital Financial Services Limited of Rs. 650.00 Lakh registered on 28 Jun 2021 with Charge ID 100455870 was modified on 02 Aug 2021.
Charges
A charge registered on 20 Jun 2018 via Charge ID 100185461 with Others was fully satisfied on 30 Jul 2021.
Charges
A charge with Tata Capital Financial Services Limited amounted to Rs. 650.00 Lakh with Charge ID 100455870 was registered on 28 Jun 2021.
Charges
A charge with Others of Rs. 591.51 Lakh registered on 20 Jun 2018 with Charge ID 100185461 was modified on 22 Jun 2020.
Appointed
Roochira Guha was appointed as Director.

17 earlier events are in the company report.

Frequently asked questions

Cradel Pharmaceuticals is an active private limited company based in Pailan Hut, West Bengal, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 21 February 1991 (35+ years old) and is registered under CIN U24233WB1991PTC050938.

Cradel Pharmaceuticals has 3 current directors:

The latest financial statements of Cradel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Cradel Pharmaceuticals is 19AABCC0202E1ZG, registered in West Bengal.

The CIN (Corporate Identification Number) of Cradel Pharmaceuticals is U24233WB1991PTC050938. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cradel Pharmaceuticals has 4 court cases on record: 2 filed by the company and 2 filed against it. 1 is pending. Most are in the high courts.

Cradel Pharmaceuticals was incorporated on 21 February 1991, making it 35+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Cradel Pharmaceuticals by revenue are Svizera Healthcare Private Limited, Gundicha Pharmaceuticals Private Limited, Lionise Pharmaceuticals Private Limited, Welsave Pharmaceuticals Private Limited, Aru Healthcare Private Limited, all in the Chemicals industry (Formulations, Pharmaceuticals, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Krishna Bakshi ceased to be Director on 29 Jan 2022. Roochira Guha was appointed as Director on 16 Jan 2019. Neelanjana Bindra was appointed as Director on 22 Mar 2013. Cradel Pharmaceuticals has 5 board changes on record in total.

Yes, Cradel Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-WB-18-0003991).

Cradel Pharmaceuticals can be reached through the website cradelpharma.com. Its registered office is in Pailan Hut, West Bengal, India.